Home > Specialists > Ophthalmology > Dr. Haiyan Wang (王海燕)

Specialty & Clinical Focus:
Ophthalmologist at Shanghai General Hospital in Shanghai, with a clinical focus on complex glaucoma, complex cataract surgery, diabetic retinopathy and other fundus diseases, minimally invasive glaucoma surgery (MIGS), and minimally invasive vitrectomy.
Professional Title & Qualifications:
-
Chief Physician
-
PhD
-
Post-doctoral fellow
Hospital & Department:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine – Department of Ophthalmology
(address: No. 85 Wujin Road, Hongkou District, Shanghai 200080)
Dr. Haiyan Wang (王海燕) - Ophthalmologist
Personal Biography
Dr. Haiyan Wang is a Chief Physician and Deputy Administrative Director of the Glaucoma Sub-specialty at Shanghai General Hospital. She holds a PhD, completed post-doctoral training in ophthalmology, and serves as a Master’s supervisor at Shanghai Jiao Tong University School of Medicine. Her clinical work focuses on complex glaucoma, cataract surgery, diabetic retinopathy and other fundus diseases, including combined cataract-glaucoma surgery, minimally invasive glaucoma surgery (MIGS), and minimally invasive vitrectomy.
Dr. Wang was a visiting scholar at the Bascom Palmer Eye Institute in the United States. Her research includes metabolic remodeling in diabetic retinopathy and clinical studies of anti-VEGF treatment for age-related macular degeneration, diabetic macular edema and neovascular glaucoma. She was nominated for the Jiulong Medical Award by Shanghai Jiao Tong University for achievements in teaching, research and medical care.
Why Consider Dr. Haiyan Wang for Your Ophthalmic Care?
Dr. Haiyan Wang combines senior clinical responsibilities in the Glaucoma Sub-specialty at Shanghai General Hospital with focused expertise in complex glaucoma, cataract surgery and fundus disease. Her experience includes combined cataract-glaucoma surgery, minimally invasive glaucoma surgery (MIGS), and minimally invasive vitrectomy for conditions including retinal detachment and diabetic retinopathy. This breadth is particularly relevant to international patients seeking a focused specialist opinion on complex or previously treated eye conditions.
Her visiting-scholar experience at the Bascom Palmer Eye Institute and active involvement in glaucoma and anti-VEGF clinical trials add an international and research-oriented dimension to her profile. A remote specialist review can be useful when prior imaging, examination reports, operative records, medication history and key questions need to be reviewed before a patient decides whether to travel to Shanghai.
Dr. Wang’s membership in the International Cochrane Collaboration and her research into diabetic retinopathy further support an evidence-informed approach to complex ophthalmic cases. Her profile may therefore be relevant to patients seeking greater clarity on glaucoma, cataract or fundus disease before arranging an in-person hospital pathway in China.
Pre-Travel Case Review & Specialist Liaison
Planning medical travel to Shanghai is easier when the specialist has reviewed the case before the trip. MedBridgeNZ coordinates a remote specialist-review pathway with Dr. Wang by helping international patients organize ophthalmic records, arrange translation where needed, and complete secure, client-authorized document transfer and appointment communication with Shanghai General Hospital.
Once the remote review pathway is confirmed, Dr. Wang will review the submitted records, provide her specialist opinion and recommendations, and address the patient’s key questions. The review can help clarify whether an in-person pathway should be considered, what additional information may be needed, and which hospital appointment and travel arrangements should be coordinated next.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
